Poland
· Delayed Price · Currency is PLN Krynica Vitamin Statistics
Total Valuation
Krynica Vitamin has a market cap or net worth of PLN 119.33 million. The enterprise value is 160.10 million.
| Market Cap | 119.33M |
| Enterprise Value | 160.10M |
Important Dates
The next estimated earnings date is Sunday, September 21, 2025.
| Earnings Date | Sep 21, 2025 |
| Ex-Dividend Date | Jul 10, 2025 |
Share Statistics
Krynica Vitamin has 12.25 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 12.25M |
| Shares Outstanding | 12.25M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 0.09% |
| Owned by Institutions (%) | 1.92% |
| Float | 1.61M |
Valuation Ratios
The trailing PE ratio is 8.35.
| PE Ratio | 8.35 |
| Forward PE | n/a |
| PS Ratio | 0.31 |
| PB Ratio | 1.26 |
| P/TBV Ratio | 1.30 |
| P/FCF Ratio | 4.69 |
| P/OCF Ratio | 3.26 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.63, with an EV/FCF ratio of 6.29.
| EV / Earnings | 11.20 |
| EV / Sales | 0.42 |
| EV / EBITDA | 4.63 |
| EV / EBIT | 7.74 |
| EV / FCF | 6.29 |
Financial Position
The company has a current ratio of 0.87, with a Debt / Equity ratio of 0.43.
| Current Ratio | 0.87 |
| Quick Ratio | 0.45 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | 1.18 |
| Debt / FCF | 1.61 |
| Interest Coverage | 6.58 |
Financial Efficiency
Return on equity (ROE) is 16.28% and return on invested capital (ROIC) is 9.30%.
| Return on Equity (ROE) | 16.28% |
| Return on Assets (ROA) | 5.78% |
| Return on Invested Capital (ROIC) | 9.30% |
| Return on Capital Employed (ROCE) | 18.22% |
| Revenue Per Employee | 1.11M |
| Profits Per Employee | 41,066 |
| Employee Count | 348 |
| Asset Turnover | 1.72 |
| Inventory Turnover | 7.45 |
Taxes
In the past 12 months, Krynica Vitamin has paid 1.82 million in taxes.
| Income Tax | 1.82M |
| Effective Tax Rate | 11.29% |
Stock Price Statistics
The stock price has decreased by -18.15% in the last 52 weeks. The beta is -0.54, so Krynica Vitamin's price volatility has been lower than the market average.
| Beta (5Y) | -0.54 |
| 52-Week Price Change | -18.15% |
| 50-Day Moving Average | 9.82 |
| 200-Day Moving Average | 9.42 |
| Relative Strength Index (RSI) | 52.24 |
| Average Volume (20 Days) | 25,079 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Krynica Vitamin had revenue of PLN 385.47 million and earned 14.29 million in profits. Earnings per share was 1.17.
| Revenue | 385.47M |
| Gross Profit | 65.24M |
| Operating Income | 20.68M |
| Pretax Income | 16.11M |
| Net Income | 14.29M |
| EBITDA | 34.55M |
| EBIT | 20.68M |
| Earnings Per Share (EPS) | 1.17 |
Balance Sheet
The company has 89,000 in cash and 40.86 million in debt, giving a net cash position of -40.77 million or -3.33 per share.
| Cash & Cash Equivalents | 89,000 |
| Total Debt | 40.86M |
| Net Cash | -40.77M |
| Net Cash Per Share | -3.33 |
| Equity (Book Value) | 94.95M |
| Book Value Per Share | 7.75 |
| Working Capital | -14.05M |
Cash Flow
In the last 12 months, operating cash flow was 36.55 million and capital expenditures -11.11 million, giving a free cash flow of 25.45 million.
| Operating Cash Flow | 36.55M |
| Capital Expenditures | -11.11M |
| Free Cash Flow | 25.45M |
| FCF Per Share | 2.08 |
Margins
Gross margin is 16.92%, with operating and profit margins of 5.36% and 3.71%.
| Gross Margin | 16.92% |
| Operating Margin | 5.36% |
| Pretax Margin | 4.18% |
| Profit Margin | 3.71% |
| EBITDA Margin | 8.96% |
| EBIT Margin | 5.36% |
| FCF Margin | 6.60% |
Dividends & Yields
This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 2.80%.
| Dividend Per Share | 0.27 |
| Dividend Yield | 2.80% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.01% |
| Shareholder Yield | 2.81% |
| Earnings Yield | 11.98% |
| FCF Yield | 21.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Krynica Vitamin has an Altman Z-Score of 2.66 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.66 |
| Piotroski F-Score | 8 |